Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The paper trail to commercialization.

Jim Kling, Laura DeFrancesco

    Nature Biotechnology
    |November 9, 2007
    PubMed
    Summary
    This summary is machine-generated.

    Authors of Nature Biotechnology have diverse commercialization strategies. Understanding these pathways can guide researchers toward successful scientific innovation and market translation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genome editing's third act.

    Nature biotechnology·2026
    Same author

    microRNAs blaze into the clinic.

    Nature biotechnology·2025
    Same author

    Mitochondrial transplants make healthy babies.

    Nature biotechnology·2025
    Same author

    Precision gene editing medicine makes history, and it's just getting started.

    Nature biotechnology·2025
    Same author

    Pheast Therapeutics: Another bite at the apple.

    Nature biotechnology·2023
    Same author

    Cartography Biosciences and Nested Therapeutics: Diamonds in the rough.

    Nature biotechnology·2023
    Same journal

    Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

    Nature biotechnology·2026
    Same journal

    Unlocking the chemical potential of filamentous fungi using prime editing.

    Nature biotechnology·2026
    Same journal

    A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

    Nature biotechnology·2026
    Same journal

    Prime editing for precise genome engineering and modulation of fungal metabolism.

    Nature biotechnology·2026
    Same journal

    Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells.

    Nature biotechnology·2026
    Same journal

    A retargeted recombinase for precise insertion of large DNA.

    Nature biotechnology·2026
    See all related articles

    Area of Science:

    • Biotechnology Commercialization
    • Scientific Publishing Impact
    • Research Translation

    Background:

    • Nature Biotechnology is a leading journal publishing high-impact research.
    • Understanding the commercialization trajectories of published authors is crucial for academic and industry stakeholders.

    Purpose of the Study:

    • To investigate the diverse pathways to commercial success undertaken by authors publishing in Nature Biotechnology.
    • To identify common strategies and factors contributing to successful market translation of scientific discoveries.

    Main Methods:

    • A survey was distributed to a cohort of authors who have published in Nature Biotechnology.
    • Data collected included information on commercialization activities, company formation, funding, and exit strategies.

    Related Experiment Videos

    Main Results:

    • Multiple distinct pathways to commercial success were identified among the surveyed authors.
    • Key factors such as academic entrepreneurship, venture capital funding, and strategic partnerships were frequently associated with successful commercialization.

    Conclusions:

    • Commercial success for scientific research is achievable through various routes.
    • The findings offer valuable insights for researchers aiming to translate their discoveries into market-ready products and ventures.